FSD Pharma Submits a Phase-1b Clinical Trial Application for Ethics Committee for its Proprietary Beverage unbuzzd(TM)

TORONTO, ON / ACCESSWIRE / March 11, 2024 / FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) ("FSD Pharma" or the "Company"), a biopharmaceutical company dedicated to building a portfolio of innovative assets and

Related Keywords

Toronto ,Ontario ,Canada ,Australia ,United States , ,Pharma Inc ,Nasdaq ,Company Clinical Trial Application ,Clinical Trial Application ,Healthy Volunteers ,Induced State ,Alcohol Intoxication ,